-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on ArcBest, Raises Price Target to $180

Benzinga·07/06/2026 13:04:20
Listen to the news
Morgan Stanley analyst Ravi Shanker maintains ArcBest (NASDAQ:ARCB) with a Overweight and raises the price target from $150 to $180.